Y-Intercept (HK)’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
275,553
+238,733
+648% +$1.25M 0.03% 769
2026
Q2
$233K Buy
+36,820
New +$181K ﹤0.01% 1528
2025
Q3
– Sell
-81,684
Closed -$484K – 1558
2025
Q2
$484K Buy
+81,684
New +$470K 0.01% 1213
2024
Q4
– Sell
-15,175
Closed -$420K – 1168
2024
Q3
$420K Buy
+15,175
New +$380K 0.03% 858
2023
Q3
– Sell
-18,906
Closed -$149K – 1046
2023
Q2
$149K Buy
+18,906
New +$132K 0.02% 987

Other funds holding ASPN

Y-Intercept (HK)'s ASPN Position: Q3 2026 in Review

Y-Intercept (HK) increased its Aspen Aerogels (ASPN) stake by 648% in Q3 2026, buying an estimated $1.25M and bringing the position to 275,553 shares worth $1.51M. The position accounts for 0.03% of the portfolio, ranked #769.

Y-Intercept (HK) first reported a position in ASPN in Q2 2023 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold ASPN as of Q3 2026.

  • Y-Intercept (HK) held 275,553 shares of Aspen Aerogels worth $1.51M as of Q3 2026.
  • Y-Intercept (HK) bought 238,733 Aspen Aerogels shares in Q3 2026, an estimated $1.25M.
  • Aspen Aerogels made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #769 holding.
  • Y-Intercept (HK) first reported a position in Aspen Aerogels in Q2 2023 and has held it in 5 quarters since.
  • 13 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.